Global Regenerative Medicine Market Forecast to 2024: Product Approvals and Growing Pipeline of Regenerative Medicine Products
Apr 10, 2019, 11:15 ET
DUBLIN, April 10, 2019 /PRNewswire/ -- The "Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The regenerative medicine market is projected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8% during the forecast period.
The rising global incidence of cancer, increasing global aging population, and technological shifts in regenerative medicine such as CAR-T cell therapy are factors expected to drive market growth during the forecast period. Economies with growing healthcare sector and high disposable income are also expected to provide opportunities for the growth of the market.
Cell-based immunotherapy & cell therapy products likely to grow at a CAGR during the forecast period
By type, the regenerative medicine market is segmented into cell-based immunotherapy & cell therapy products, tissue-engineered products, and gene therapy products. The cell-based immunotherapy & cell therapy products segment dominates this market in 2019 and is the fastest growing segment due to increasing launches of novel cell therapies, increasing demand for novel treatments with fewer side effects for the treatment of cancer are the major factors driving the growth of this market segment.
Musculoskeletal Disorders application segment accounted for the largest share of the regenerative medicine market in 2019 and the oncology segment expected to achieve the highest growth rate in the future
By application, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. Musculoskeletal disorder applications segment likely to account for the largest share of this market and oncology is likely to register the highest CAGR during the forecast period. The surging incidence rate of orthopedic diseases & injuries and rising geriatric population are the key drivers for the growth of this market segment.
North America is expected to attain fastest growth rate and dominated the regenerative medicine market in 2019
North America, which includes the US, & Canada, accounted for the largest share of the regenerative medicine market. The large share of this market segment can be attributed to the increasing incidence of chronic wounds, diabetes, leukemia and musculoskeletal diseases in this region.
The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Regenerative Medicine: Market Overview
4.2 Regenerative Medicine Market, By Type & Application (2019)
4.3 Geographical Snapshot of the Regenerative Medicine Market
5 Market Overview
5.1 Introduction
5.2 Clinical Trials for Regenerative Medicine
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Prevalence of Chronic Diseases and Genetic Disorders
5.3.1.2 Rising Government Investments in Regenerative Medicine Research
5.3.1.3 Product Approvals and Growing Pipeline of Regenerative Medicine Products
5.3.2 Restraints
5.3.2.1 Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
5.3.3 Opportunities
5.3.3.1 Implementation of the 21st Century Cures Act
5.3.3.2 Rising Demand for Organ Transplantation
6 Regenerative Medicine Market, By Type
6.1 Introduction
6.2 Cell-Based Immunotherapy & Cell Therapy Products
6.2.1 Allogeneic Products
6.2.2 Autologous Products
6.3 Tissue-Engineered Products
6.4 Gene Therapy Products
7 Regenerative Medicine Market, By Application
7.1 Introduction
7.2 Musculoskeletal Disorders
7.2.1 Musculoskeletal Disorders Segment Will Continue to Dominate the Regenerative Medicine Market in 2024
7.3 Wound Care
7.3.1 Increasing Prevalence of Target Conditions to Drive the Growth of This Application Segment
7.4 Oncology
7.4.1 Increasing Prevalence of Cancer to Support Market Growth
7.5 Ocular Disorders
7.5.1 Growing Number of Product Approvals to Support Market Growth
7.6 Diabetes
7.6.1 Increasing Incidence of Diabetes and the Growing Focus of Companies on Developing Regenerative Medicine for the Treatment of Diabetes are the Key Factors Driving Market Growth
7.7 Other Applications
8 Regenerative Medicine Market, By Region
9 Competitive Landscape
9.1 Overview
9.2 Market Ranking Analysis, 2017
9.3 Key Strategies
9.4 Competitive Leadership Mapping (2018)
9.5 Competitive Leadership Mapping for Start-Ups (2018)
10 Company Profiles
- Integra Lifesciences
- Kite Pharma (Subsidiary of Gilead Sciences)
- Mimedx Group
- Novartis AG
- Organogenesis
- Osiris Therapeutics
- Spark Therapeutics
- Stryker
- Vericel
- Wright Medical
For more information about this report visit https://www.researchandmarkets.com/r/ydwi3g
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets